Director, Safety & Pharmacovigilance (PV)

Ocugen

Malvern (Chester County)

On-site

USD 180,000 - 240,000

Full time

10 days ago
Application generator

Don’t send a generic resume — generate a resume and cover letter tailored to this exact role.

Get past ATS filters

Job summary

Ocugen in Malvern, PA is seeking a Director of Pharmacovigilance & Patient Safety to lead safety activities across its ocular gene-therapy portfolio. This hands-on role oversees safety surveillance, case assessment, signal detection, benefit–risk evaluation, and regulatory reporting.

The Director collaborates with Clinical Development, Regulatory Affairs, Biostatistics, Data Management, QA, and external vendors to identify and address safety risks.

Qualifications

  • MD or DO strongly preferred and board certification preferred.
  • Minimum 7 years of pharmacovigilance or drug safety experience in biotech/pharma.
  • Experience assessing complex cases and leading signal and benefit–risk activities.
  • Experience authoring or reviewing DSURs, IND annual reports, safety sections, and regulatory responses.

Responsibilities

  • Serve as the safety physician for assigned programs, reviewing safety narratives and assessing seriousness, causality, and clinical significance.
  • Review SAEs, SUSARs, AESIs, pregnancy cases, and other medically significant safety narratives.
  • Analyze safety data, evaluate signals, and recommend follow-up or risk-mitigation actions.
  • Lead benefit–risk assessments and communicate conclusions to cross-functional teams and leadership.
  • Provide safety input to protocols, ICFs, Investigator Brochures, and regulatory submissions.
  • Prepare DSURs, IND annual reports, and safety updates; respond to health authorities.
  • Develop safety surveillance strategies for ocular gene therapy and monitor safety events.
  • Oversee PV day-to-day activities: case processing, medical review, reconciliation, and reporting.
  • Maintain Safety Management Plans and PV procedures; ensure inspection readiness.
  • Lead signal-detection activities and support DSMB/IDMC meetings and vendor oversight.

Skills

Pharmacovigilance
Medical leadership
Adverse event assessment
Signal detection
Regulatory submissions
Vendor oversight
Cross-functional collaboration

Education

MD/DO

Tools

Argus/ArisGlobal LifeSphere

Job description

Position

The Director, Pharmacovigilance & Patient Safety provides medical and operational leadership for safety activities across Ocugen’s clinical-stage portfolio of ocular gene therapies. This hands‑on role is responsible for safety surveillance, case assessment, signal detection, benefit–risk evaluation, aggregate reporting, vendor oversight, and inspection readiness.

Position

The Director, Pharmacovigilance & Patient Safety provides medical and operational leadership for safety activities across Ocugen’s clinical-stage portfolio of ocular gene therapies. This hands‑on role is responsible for safety surveillance, case assessment, signal detection, benefit–risk evaluation, aggregate reporting, vendor oversight, and inspection readiness. The Director works closely with Clinical Development, Clinical Operations, Regulatory Affairs, Biostatistics, Data Management, Quality Assurance, and external vendors to ensure safety risks are identified, evaluated, communicated, and addressed promptly.

Responsibilities
  • Serve as the safety physician for assigned programs, providing medical assessment of adverse events, including seriousness, expectedness, causality, and clinical significance.
  • Personally review and approve SAEs, SUSARs, AESIs, pregnancy cases, and other medically significant safety narratives.
  • Review emerging and cumulative safety data, evaluate potential signals, and recommend appropriate follow‑up or risk‑mitigation actions.
  • Lead benefit–risk assessments and communicate conclusions and recommendations to cross‑functional teams and senior leadership.
  • Provide safety input to protocols, informed consent forms, Investigator Brochures, clinical study reports, and regulatory submissions.
  • Author or medically review DSURs, IND annual reports, Investigator Brochure safety updates, aggregate reports, and health authority responses.
  • Develop and maintain program‑specific safety surveillance strategies for ocular gene therapy, including ocular inflammation, procedure‑related events, immunogenicity, vector shedding, and long‑term follow‑up.
  • Direct day‑to‑day PV activities, ensuring accurate and timely case processing, medical review, reconciliation, and regulatory reporting.
  • Maintain Safety Management Plans, Safety Data Exchange Agreements, PV procedures, and inspection‑ready documentation.
  • Lead signal‑detection and internal safety‑review activities and support DSMB/IDMC meetings and recommendations.
  • Provide active sponsor oversight of PV vendors, including review of quality, timelines, compliance metrics, and corrective actions.
  • Lead or support PV audits, inspections, deviations, CAPAs, and process improvements.
  • Escalate significant safety or compliance risks promptly, with a clear assessment and recommended action.
  • Provide safety training to employees, investigators, and vendors as needed.
Qualifications
  • MD or DO strongly preferred.
  • At least seven years of pharmacovigilance or drug safety experience in the biotechnology or pharmaceutical industry, including hands‑on safety physician responsibilities.
  • Demonstrated experience assessing complex cases, evaluating aggregate safety data, and leading signal and benefit‑risk activities.
  • Experience authoring or medically reviewing DSURs, IND annual reports, Investigator Brochure safety sections, clinical study reports, and regulatory responses.
  • Working knowledge of FDA regulations, EU GVP, ICH E2 guidance, MedDRA, and CIOMS conventions.
  • Experience overseeing PV CROs, case‑processing vendors, and safety database activities.
  • Experience supporting regulatory inspections or PV audits.
  • Strong judgment, communication, and organizational skills, with the ability to work both independently and cross‑functionally in a fast‑paced biotech environment.
  • Willingness to personally execute critical safety work rather than relying solely on vendors or larger teams.
Preferred
  • Gene therapy, cell therapy, or other advanced therapy experience, particularly with AAV‑based programs.
  • Ophthalmology, retinal disease, or rare disease experience.
  • Experience supporting pivotal‑stage programs, BLA/MAA preparation, or long‑term gene therapy follow‑up.
  • Experience with Argus, ArisGlobal LifeSphere, or a comparable safety database.
Working Conditions

This position operates in an office setting, in person. Job may additionally require incumbent to be available outside of these hours to handle priority business needs.

Ocugen is an equal opportunity employer. In order to provide equal employment and advancement opportunities to all individuals, we make all of our employment decisions based upon merit, qualifications, abilities, and an individual’s conduct and performance. We will not make any of our decisions, and will not discriminate against any employee or applicant, on the basis of race, color, religion, creed, national origin or ancestry, ethnicity, sex (including pregnancy), gender (including sexual orientation, gender identity and status as a transgender or transsexual individual), age, physical or mental disability, citizenship, past, current or prospective service in the uniformed services, genetic information, or any other characteristic protected from discrimination under the law. Ocugen complies with applicable federal, state and local laws governing nondiscrimination in employment.

Get your free, confidential resume review.
or drag and drop your file here.
Similar jobs

Similar jobs worth comparing

Director, Safety & Pharmacovigilance (PV)
Director, Safety & Pharmacovigilance (PV)

OCUGEN OPCO INC • Malvern

On-site
USD 180,000 - 240,000
Director, Safety & Pharmacovigilance (PV)
Director, Safety & Pharmacovigilance (PV)

OCUGEN OPCO INC • Malvern (AR)

On-site
USD 180,000 - 240,000
Director, Safety & Pharmacovigilance (PV)
Director, Safety & Pharmacovigilance (PV)

Scorpion Therapeutics • Malvern

On-site
USD 190,000 - 280,000
Senior Director, Safety & Pharmacovigilance
Senior Director, Safety & Pharmacovigilance

OCUGEN OPCO INC • Malvern (AR)

On-site
USD 180,000 - 240,000
Director, Patient Safety & Pharmacovigilance
Director, Patient Safety & Pharmacovigilance

OCUGEN OPCO INC • Malvern

On-site
USD 180,000 - 240,000
Medical Director, Pharmacovigilance
Medical Director, Pharmacovigilance

Vivid Resourcing • Boston (MA)

On-site
USD 150,000 - 250,000
AD/ Director, Clinical Regulatory Affairs Gene Therapy
AD/ Director, Clinical Regulatory Affairs Gene Therapy

BioSpace • Malvern

On-site
USD 180,000 - 260,000
AD/ Director, Clinical Regulatory Affairs Gene Therapy
AD/ Director, Clinical Regulatory Affairs Gene Therapy

Ocugen • Malvern

On-site
USD 180,000 - 240,000
PV & Patient Safety Director, Ophthalmic Gene Therapy
PV & Patient Safety Director, Ophthalmic Gene Therapy

Ocugen • Malvern

On-site
USD 180,000 - 240,000
Director, Gene Therapy Regulatory Strategy
Director, Gene Therapy Regulatory Strategy

Ocugen • Malvern

On-site
USD 180,000 - 240,000